Further, as a tumor suppressor, high expression of THRβ1 has been associated with improved BC-specific survival and its downregulation of the JAK/STAT/Cyclin D pathway is a well-recognized mechanism of endocrine resistance [15]. This evidence concerns the gene SOAT1 and breast cancer.